Skip to main content

Table 1 Top 20 TF-target disease associations. The “Literature Rich” gene universe is used for the association detection

From: Systematic target function annotation of human transcription factors

TF

Target disease

log2(OR)a

P valueb

Evidencec

ATF3

Lysosomal storage disease

4.5

3.9 × 10-09

BRCA1

Mitochondrial metabolism disease

3.1

3.7 × 10-09

CTBP2

Heart septal defect

6.9

4.4 × 10-10

Mousef [149]

Congenital heart disease

6.5

1.6 × 10-09

Mousef [149]

ETS1

Organ system cancer

2.6

1.2 × 10-08

Mutationd [150]

GATA1

Acute porphyria

7.4

9.8 × 10-09

Mutationd [50]

HNF4A

Mitochondrial metabolism disease

3.0

5.3 × 10-09

Mutation in MODY1d [140]

NFE2

Lysosomal storage disease

5.7

4.8 × 10-12

Lipid storage disease

6.0

5.8 × 10-09

RFX2

Bardet-Biedl syndrome

5.5

1.1 × 10-12

Mousef [144, 145]

SOX10

Waardenburg’s syndrome

11.4

2.0 × 10-09

Mutationd [141]

SUZ12

Heart septal defect

6.2

7.4 × 10-09

Mousef [151]

TP53

Organ system cancer

3.5

1.5 × 10-19

Mutations in multiple cancerd

Cancer

3.5

3.6 × 10-19

Types [152]

Disease of cellular proliferation

3.4

1.7 × 10-18

Reproductive organ cancer

4.8

1.2 × 10-08

USF1

Disease of metabolism

2.2

1.3 × 10-10

Association with FCHLe [153, 154]

Inherited metabolic disorder

2.2

7.5 × 10-09

USF2

Lysosomal storage disease

4.1

1.3 × 10-09

Disease of metabolism

2.3

2.8 × 10-09

  1. alog2(OR), log2 transformed odds ratio
  2. bP value from single-tailed Fisher’s exact test for odds ratio > 1
  3. cEvidence lists published genetic evidence directly support the association of the TF with the disease
  4. dMutation mutations of the TF are observed in the disease or closely related diseases
  5. eAssociation, the TF gene locus is genetically associated with the disease or related diseases
  6. fMouse mouse model shows phenotypes directly related to the disease.
  7. Non-genetic evidence in the literature is not considered.
  8. MODY1 maturity-onset diabetes of the young, FCHL familial combined hyperlipidemia